112 related articles for article (PubMed ID: 1033176)
1. Dehydrodicaffeic acid dilactone, an inhibitor of catechol-O-methyl transferase.
Kumada Y; Naganawa H; Iinuma H; Matsuzaki M; Takeuchi T
J Antibiot (Tokyo); 1976 Sep; 29(9):882-9. PubMed ID: 1033176
[TBL] [Abstract][Full Text] [Related]
2. Biochemical activities of the derivatives of dehydrodicaffeic acid dilactone.
Kumada Y; Naganawa H; Takeuchi T; Umezawa H
J Antibiot (Tokyo); 1978 Feb; 31(2):105-11. PubMed ID: 204621
[TBL] [Abstract][Full Text] [Related]
3. Inhibition of Dopa decarboxylase by caffeic acid and related compounds: structure-activity relationships.
Rosei MA
Pharmacol Res Commun; 1987 Oct; 19(10):663-71. PubMed ID: 3441482
[TBL] [Abstract][Full Text] [Related]
4. New isoflavones, inhibiting catechol-O-methyltransferase, produced by Streptomyces.
Chimura H; Sawa T; Kumada Y; Naganawa H; Matsuzaki M
J Antibiot (Tokyo); 1975 Sep; 28(9):619-26. PubMed ID: 1184476
[TBL] [Abstract][Full Text] [Related]
5. Inhibitory activities and inhibition specificities of caffeic acid derivatives and related compounds toward 5-lipoxygenase.
Sugiura M; Naito Y; Yamaura Y; Fukaya C; Yokoyama K
Chem Pharm Bull (Tokyo); 1989 Apr; 37(4):1039-43. PubMed ID: 2766406
[TBL] [Abstract][Full Text] [Related]
6. Interactions between levodopa and other drugs: significance in the treatment of Parkinson's disease.
Bianchine JR; Sunyapridakul L
Drugs; 1973; 6(5):364-88. PubMed ID: 4787755
[No Abstract] [Full Text] [Related]
7. BIA 3-202, a novel catechol-O-methyltransferase inhibitor, enhances the availability of L-DOPA to the brain and reduces its O-methylation.
Parada A; Loureiro AI; Vieira-Coelho MA; Hainzl D; Soares-da-Silva P
Eur J Pharmacol; 2001 May; 420(1):27-32. PubMed ID: 11412836
[TBL] [Abstract][Full Text] [Related]
8. Synthesis of bridged catechol-homocysteine derivatives as potential inhibitors of catechol O-methyltransferase.
Lever OW; Hyman C; White HL
J Pharm Sci; 1984 Sep; 73(9):1241-4. PubMed ID: 6491941
[TBL] [Abstract][Full Text] [Related]
9. Catechol O-methyltransferase. 10. 5-Substituted 3-hydroxy-4-methoxybenzoic acids (isovanillic acids) and 5-substituted 3-hydroxy-4-methoxybenzaldehydes (isovanillins) as potential inhibitors.
Borchardt RT; Huber JA; Houston M
J Med Chem; 1982 Mar; 25(3):258-63. PubMed ID: 7069704
[TBL] [Abstract][Full Text] [Related]
10. Letter: Methylspinazarin and dihydromethylspinazarin, catechol-O-methyl transferase inhibitors produced by Streptomyces.
Chimura H; Sawa T; Takita T; Matsuzaki M; Takeuchi T
J Antibiot (Tokyo); 1973 Feb; 26(2):112-4. PubMed ID: 4781283
[No Abstract] [Full Text] [Related]
11. Substrate stereospecificity and selectivity of catechol-O-methyltransferase for DOPA, DOPA derivatives and alpha-substituted catecholamines.
Gordonsmith RH; Raxworthy MJ; Gulliver PA
Biochem Pharmacol; 1982 Feb; 31(3):433-7. PubMed ID: 6803810
[TBL] [Abstract][Full Text] [Related]
12. Peripheral and central inhibitors of catechol-O-methyl transferase: effects on liver and brain COMT activity and L-DOPA metabolism.
Brannan T; Prikhojan A; Yahr MD
J Neural Transm (Vienna); 1997; 104(1):77-87. PubMed ID: 9085195
[TBL] [Abstract][Full Text] [Related]
13. Homologs of dopa, alpha-methyldopa, and dopamine as potential cardiovascular drugs.
Winn M; Rasmussen R; Minard F; Kyncl J; Plotnikoff N
J Med Chem; 1975 Apr; 18(4):434-7. PubMed ID: 1079053
[TBL] [Abstract][Full Text] [Related]
14. Thiamine absorption in the rat. IV. Effects of caffeic acid (3,4-dihydroxycinnamic acid) upon absorption and active transport of thiamine.
Schaller K; Höller H
Int J Vitam Nutr Res; 1976; 46(2):143-8. PubMed ID: 1032624
[TBL] [Abstract][Full Text] [Related]
15. Isolation of isoflavones inhibiting DOPA decarboxylase from fungi and streptomyces.
Umezawa H; Tobe H; Shibamoto N; Nakamura F; Nakamura K
J Antibiot (Tokyo); 1975 Dec; 28(12):947-52. PubMed ID: 1206008
[TBL] [Abstract][Full Text] [Related]
16. BRL 8242 (2-[2-benzimidazolyl]-amino-2-imidazoline dihydrochloride), a new inhibitor of dopamine-beta-hydroxylase with antihypertensive activity.
Claxton IM; Palfreyman MG; Poyser RH; Whiting RL
Eur J Pharmacol; 1976 May; 37(1):179-88. PubMed ID: 1278239
[TBL] [Abstract][Full Text] [Related]
17. Nitrocatechol Derivatives of Chalcone as Inhibitors of Monoamine Oxidase and Catechol-O-Methyltransferase.
Engelbrecht I; Petzer JP; Petzer A
Cent Nerv Syst Agents Med Chem; 2018; 18(2):115-127. PubMed ID: 29697034
[TBL] [Abstract][Full Text] [Related]
18. Studies on non-sesquiterpenoid constituents of Gaillardia pulchella. II. Less lipophilic substances, methyl caffeate as an antitumor catecholic.
Inayama S; Harimaya K; Hori H; Ohkura T; Kawamata T; Hikichi M; Yokokura T
Chem Pharm Bull (Tokyo); 1984 Mar; 32(3):1135-41. PubMed ID: 6744486
[No Abstract] [Full Text] [Related]
19. Effects of enzyme inhibitors of catecholamine metabolism and of haloperidol on the pancreatic secretion induced by L-DOPA and by dopamine in dogs.
Furuta Y; Hashimoto K; Iwatsuki K; Takeuchi O
Br J Pharmacol; 1973 Jan; 47(1):77-84. PubMed ID: 4717022
[TBL] [Abstract][Full Text] [Related]
20. Mutagenic activity of some coffee flavor ingredients.
Fung VA; Cameron TP; Hughes TJ; Kirby PE; Dunkel VC
Mutat Res; 1988 Feb; 204(2):219-28. PubMed ID: 3278213
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
